#United States #Bozeman #Golden Helix #VarSeq 3 #VSWarehouse 3

Golden Helix's New Era in Genomic Analysis

Golden Helix is setting the stage for innovation in genomic analysis with the launch of VarSeq 3 and VSWarehouse 3. This release signifies a crucial advancement in secondary and tertiary genomic analysis on an enterprise scale. The tools are designed to meet the rising demands of labs of all sizes and are particularly beneficial for national genome initiatives and smaller diagnostic laboratories.

Key Features and Benefits

Cloud-Optimized Deployments

One of the standout features is the cloud-native deployment options that are optimized for platforms such as AWS and Azure. The flexibility to use hybrid and on-premise infrastructure caters to a broad spectrum of user needs, allowing for easy integration and dynamic scaling based on demand. Whether a lab is operating entirely in the cloud or utilizing a combination of on-premise resources, Golden Helix ensures that users maintain total control over their data.

Secure Collaboration and Data Federation

The new capabilities extend to data federation, enabling a secure environment for multi-site collaboration. Fine-grained access controls help protect sensitive genomic data, allowing seamless coordination and cooperation among institutions while ensuring compliance with relevant regulations. This feature is particularly useful for larger genome initiatives, where data coordination across various research centers is pivotal.

Per-Sample Licensing Models

Golden Helix aims to democratize access to its powerful tools through the introduction of per-sample licensing options. By offering packages tailored for smaller labs or those with fluctuating sample volumes, Golden Helix breaks down financial barriers, permitting more labs to leverage this advanced technology without the burden of large upfront investments.

Integration of Secondary Analysis

The upcoming release also introduces an integrated analysis layer that streamlines the connection between secondary analysis and clinical interpretation workflows. Labs will benefit from automatic ingestion and storage of variant calls, alignment metrics, and quality control outputs from diverse tools, all within a single cohesive environment, thus improving efficiency and analytical accuracy.

Comprehensive Genomic Workflow Automation

Automation is at the forefront of these tools, addressing various clinical domains such as pharmacogenomics and carrier screening. The ability to automate full genomic workflows simplifies processes for labs, allowing them to focus more on critical tasks rather than repetitive data handling.

Long-Read Genomic Support

Golden Helix further enhances its offerings with support for long-read sequencing technologies. This development is crucial for the diagnosis of rare genetic disorders, enabling accurate detection of repeat expansions—a significant step forward for conditions such as Huntington's disease and Fragile X syndrome. The integration of these advanced technologies within both secondary and tertiary workflows is set to transform how genomic analysis is approached in clinical settings.

Upcoming Presentation and Demonstration

Golden Helix will showcase its innovations at the European Society of Human Genetics (ESHG) conference from May 24 to 26, 2025, in Milan, Italy. Attendees are encouraged to visit Booth 510, where live demonstrations will be held, and discussions on the future of genomic analysis will take place. This platform provides an excellent opportunity for professionals in the field to explore how Golden Helix's solutions can be tailored to meet their specific needs.

Conclusion

With over 25 years of experience, Golden Helix remains at the forefront of bioinformatics solutions. The release of VarSeq 3 and VSWarehouse 3 reaffirms their commitment to empowering healthcare providers by unlocking potential avenues for genetic research and diagnostics. For those looking to harness the power of genomic data, this latest offering promises unparalleled scalability, flexibility, and advanced functionalities, tailored to meet the demands of today's evolving healthcare landscape.

For inquiries or to request a demonstration of the new tools, visit www.goldenhelix.com.